Suchergebnisse - "Salazar, Ramon"

PubPharm (11)

1

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

enthalten in: Nature cancer | 2022

von Herpers, B. | Eppink, B. | James, M. | +36

CommentIn: Nat Cancer. 2022 Apr;3(4):379-380. - PMID 35469016

2

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

3

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer

enthalten in: Molecular cancer therapeutics | 2017

von Santos, C. | Azuara, D. | Garcia-Carbonero, R. | +19

4

Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer

enthalten in: Oncotarget | 2016

von Queralt, B. | Cuyàs, E. | Bosch-Barrera, J. | +6

5

Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies

enthalten in: Molecular cancer therapeutics | 2016

von Azuara, D. | Santos, C. | Lopez-Doriga, A. | +15

6

Optimizing Anti-EGFR Therapy in Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Salazar, R. | Ciardiello, F.

CommentOn: Clin Cancer Res. 2015 Dec 15;21(24):5469-79. - PMID 26341920

7

Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer

enthalten in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting | 2015

von Dienstmann, R. | Salazar, R. | Tabernero, J.

8

Paracrine network : another step in the complexity of resistance to EGFR blockade?

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Salazar, R. | Capellà, G. | Tabernero, J.

CommentOn: Clin Cancer Res. 2014 Dec 15;20(24):6429-38. - PMID 24916700

9

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

enthalten in: Nature | 2012

von Prahallad, A. | Sun, C. | Huang, S. | +6

CommentIn: Nat Rev Clin Oncol. 2012 Mar;9(3):127. - PMID 22310739

10

Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumors

enthalten in: Targeted oncology | 2009

von Capdevila, J. | Salazar, R.